Antigen-specific immunotherapy for autoimmune diseases

Bibliography

• JACOBSON DL, GANGE SJ, ROSE NR, GRAHAM NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. (1997) 84:223-243.
   PubMedGoogle Scholar
• LEACH MW, SNYDER EA, SINHA DP, ROSENBLUM IY: Safetay evaluation of recombinant human interleukine-4 I Preclinical studies. Clin. Immunol. Immunopathol. (1997) 83:8-11.
   PubMedGoogle Scholar
• OLSEN NJ, STEIN CM: New drugs for rheumatoid arthritis. N. Engl. J. Med. (2004) 350:2167-2179.
   PubMed Web of Science ®Google Scholar
• EUVRARD S, KANITAKIS J, CLAUDY A: Skin cancers in organ transplant recipients. N. Engl. J. Med. (2003) 348:1681-1691.
   PubMed Web of Science ®Google Scholar
• FELDMAN M, MAINI R: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. (2003) 9:1245-1250.
   PubMed Web of Science ®Google Scholar
• KEANE J, GERSHON S, WISE RP et al.: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. (2001) 345:1098-1104.
   PubMed Web of Science ®Google Scholar
• HYRICH KL, SILMAN AJ, WATSON KD, SYMMONS DP:　 Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann. Rheum. Dis. (2004) 63:1538-1543.
   PubMed Web of Science ®Google Scholar
• MILLER DH, KHAN OA, SHERERNATA WA et al.: A controlled trial of Natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. (2003) 348:15-23.
   PubMed Web of Science ®Google Scholar
• COLES AJ, WING M, SMITH S et al.: Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet (1999) 354:1691-1695.
   PubMed Web of Science ®Google Scholar
• KREMER JM, WESTHOVENS R, LEON M et al.: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. (2003) 349:1907-1915.
   Google Scholar
• CROFT M, BRADLEY LM, SWAIN SL: Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. (1994) 152:2675-2685.
   PubMed Web of Science ®Google Scholar
• GARCIA S, DISANTO J, STOCKINGER B: Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity (1999) 11:163-171.
   PubMed Web of Science ®Google Scholar
• DE VITA S, ZAJA F, SACCO S et al.: Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenic role of B cells. Arthritis Rheum. (2002) 46:2029-2033.
   PubMed Web of Science ®Google Scholar
• HOLERS VM: The complement system as a therapeutic target in autoimmunity. Clin. Immunol. (2003) 107:140-151.
   PubMed Web of Science ®Google Scholar
• LAWTON JA, GHOSH P: Novel therapeutic strategies based on toll-like receptor signaling. Curr. Opin. Chem. Biol. (2003) 7:446-451.
   PubMed Web of Science ®Google Scholar
• MCDEVITT H: Specific antigen vaccination to treat autoimmune disease. Proc. Natl. Acad. Sci. USA (2004) 101:1462-1463.
   Google Scholar
• MONNEAUX F, MULLER S: Peptide-based immunotherapy of systemic lupus erythematosus. Autoimmun. Rev. (2004) 3:16-24.
   PubMed Web of Science ®Google Scholar
• TSALIK EL: DNA-based immunotherapy to treat atopic disease. Ann. Allergy Asthma Immunol. (2005) 95:403-410.
   PubMed Web of Science ®Google Scholar
• QUINTANA FJ, CARMI P, MOR F, COHEN IR: Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol. (2002) 169:3422-3428.
   PubMed Web of Science ®Google Scholar
• GARREN H, RUIZ PJ, WATKINS TA et al.: Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity (2001) 15:15-22.
   PubMed Web of Science ®Google Scholar
• FARIA AM, WEINER HL: Oral tolerance. Immunol. Rev. (2005) 206:232-259.
   PubMed Web of Science ®Google Scholar
• CHOY EH, SCOTT DL, KINGSLEY GH et al.: Control of rheumatoid arthritis by oral tolerance. Arthritis Rheum. (2001) 44:1993-1997.
   PubMed Web of Science ®Google Scholar
• ERGUN-LONGMIRE B, MARKER J, ZEIDLER A et al.: Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes. Ann. NY Acad. Sci. (2004) 1029:260-277.
   PubMed Web of Science ®Google Scholar
• BIELEKOVA B, GOODWIN B, RICHERT N et al.: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a Phase II clinical trial with an altered peptide ligand. Nat. Med. (2000) 6:1167-1175.
   PubMed Web of Science ®Google Scholar
• JYOTHI MD, FLAVELL RF GEIGER TL: Target autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes. Nat. Med. (2002) 20:1215-1220.
   Google Scholar
• SRIVASTAVA PK: Therapeutic cancer vaccines. Curr. Opin. Immunol. (2006) 18:201-205.
   PubMed Web of Science ®Google Scholar
• MILLER JF, KURTS C, ALLISON J et al.: Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol. Rev. (1998) 165:267-277.
   PubMed Web of Science ®Google Scholar
• LO J, CLARE-SALZLER MJ: Dendritic cell subsets and Type I diabetes: focus upon DC-based therapy. Autoimmun. Rev. (2006) 5:419-423.
   PubMed Web of Science ®Google Scholar
• NOURI-SHIRAZI M, THOMSON AW: Dendritic cells as promoters of transplant tolerance. Expert Opin. Biol. Ther. (2006) 6:325-339.
   PubMed Web of Science ®Google Scholar
• REA D, VAN KOOTEN C, VAN MEIJGAARRDEN KE et al.: Glucocorticoids transfer CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood (2000) 95:3162-3167.
   PubMed Web of Science ®Google Scholar
• ADORINI L, PENNA G, GIARRATANAN N, USKOKOVICM: Tolerogenic dendritic cells induced by vitamin D receptor ligand enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. (2003) 88:227-233.
   PubMed Web of Science ®Google Scholar
• MARTIN E, O’SULLIVAN B, LOW P, THOMAS R: Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity (2003) 18:155-157.
   PubMed Web of Science ®Google Scholar
• FIGDOR CG, DE VRIES IJ, LESTERHUIS WJ, MELIEF CJ: Dendritic cell immunotherapy: mapping the way. Nat. Med. (2004) 10:475-480.
   PubMed Web of Science ®Google Scholar
• SAKAGUCHI S: Naturally arising Foxp3-expresing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. (2005) 6:345-352.
   PubMed Web of Science ®Google Scholar
• BLUESTONE JA, TANG Q: Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. USA (2004) 101:14622-14626.
   PubMed Web of Science ®Google Scholar
• TANG Q, HENRIKSEN KJ, BI M et al.: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1455-1465.
   PubMed Web of Science ®Google Scholar
• TARBELL KV, YAMAZAKI S, OLSON K, TOY P, STEINMAN RM: CD25+CD4+ T cells, expanded with dendritic cells presenting an single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1467-1477.
   PubMed Web of Science ®Google Scholar
• SHAW MK, LORENS JB, DHAWAN A et al.: Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med.. (1997) 185:1711-1714.
   PubMed Web of Science ®Google Scholar
• MATHISEN PM, YU M, JOHNSON JM, DRAZB JA, TUOHY VK: Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. (1997) 186:159-164.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA A, SEROOGY CM, MATTHEW SR et al.: Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. (2001) 107:1293-1301.
   PubMed Web of Science ®Google Scholar
• SETOGUCHI K, MISAKI Y, ARAKI Y et al.: Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J. Immunol. (2000) 165:5980-5986.
   PubMed Web of Science ®Google Scholar
• LEHMANN PV, FORSTHUBER T, MILLER A, SERCARZ EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (1992) 358:155-157.
   PubMed Web of Science ®Google Scholar
• VANDERLUGT CL, MILLER SD: Epitope spreading in immune-mediated diseses:implications for immunotherapy Nat. Rev. Immunol. (2002) 2:85-95.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO K, MASUKO-HONGO K, TANAKA A et al.: Establishment and application of a novel T cell clonality analysis using single-strand conformation polymorphism of T cell receptor messenger signals. Hum. Immunol. (1996) 48:23-31.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO K, SAKODA H, NAKAJIMA T et al.: Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. (1992) 4:1219-1223.
   PubMed Web of Science ®Google Scholar
• IWAKURA Y, TOSU M, YOSHIDA E et al.: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science (1991) 253:1026-1028.
   PubMed Web of Science ®Google Scholar
• KOBARI Y, MISAKI Y, SETOGUCHI K et al.: T cell accumulating in the inflamed joints of spontaneous murine model of rheumatoid arthritis become restricted to common clonotypes during disease progression. Int. Immunol. (2004) 16:131-138.
   PubMed Web of Science ®Google Scholar
• KOMAGATA Y, MASUKO K, TASHIRO F et al.: Clonal prevalence of T cells infiltrating into the pancreas of prediabetic non-obese diabetic mice. Int. Immunol. (1996) 8:807-814.
   PubMed Web of Science ®Google Scholar
• ZHOU G, FUJIO K, SADAKATA A et al.: Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice. Clin. Exp. Immunol. (2004) 136:448-455.
   PubMed Web of Science ®Google Scholar
• VAN DEN ELZEN P, MENEZES JS, AMETANI A et al.: Limited clonality in autoimmunity: drivers and regulators. Autoimmun. Rev. (2004) 3:524-529.
   PubMed Web of Science ®Google Scholar
• HUANG JC, OBER RJ, WARD ES: The central residues of a T cell receptor sequence motif are key determinants of autoantigen recognition in murine experimental autoimmune encephalomyelitis. Eur. J. Immunol. (2005) 35:299-304.
   PubMed Web of Science ®Google Scholar
• KENT SC, CHEN Y, BREGOLI L et al.: Expanded T cells from pancreatic lymph nodes of Type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 435:224-228.
   PubMed Web of Science ®Google Scholar
• AMRANI A, VERDGUER J, SERRA P, TAFURO S, TAN R, SANTAMARIA P: Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature (2000) 406:739-742.
   PubMed Web of Science ®Google Scholar
• KEDZIERSKA K, TURNER SJ, DOHERTY P: Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA (2004) 101:4942-4947.
   PubMed Web of Science ®Google Scholar
• MALHERBE L, HAUSL C, TEYTON L, MCHEYZER-WILLIAMS MG: Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity (2004) 21:669-679.
   PubMed Web of Science ®Google Scholar
• FACCHINETTI A, SANTA SD, MEZZALIRA S, ROSATO A, BIASI G: A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance. J. Immunol. (2005) 174:5398-5406.
   PubMed Web of Science ®Google Scholar
• FUJIO K, MISAKI Y, SETOGUCHI K et al.: Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J. Immunol. (2000) 165:528-532.
   PubMed Web of Science ®Google Scholar
• FUJIO K, OKAMOTO A, TAHARA H et al.: Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J. Immunol. (2004) 173:2118-2125.
   PubMed Web of Science ®Google Scholar
• KALIYAPERULAL A, MOHAN C, WU W, DATTA SK: Nucleomosomal peptide epitope for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. (1996) 183:2459-2469.
   PubMed Web of Science ®Google Scholar
• MOHAN C, ADEM S, STANIK V, DATTA SK: Nucleosome: a major immunogen for pathogenic autoantigen-inducing T cells of lupus. J. Exp. Med. (1993) 177:1367-1381.
   PubMed Web of Science ®Google Scholar
• FUJIO K, OKAMOTO A, ARAKI Y et al.: Gene therapy of arthritis with TCR isolated from the inflamed paw. J. Immunol. (2006) 177:8140-8147.
   PubMed Web of Science ®Google Scholar
• TAHARA H, FUJIO K, ARAKI Y et al.: Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte. J. Immunol. (2003) 171:2154-2160.
   PubMed Web of Science ®Google Scholar
• MORGAN RA, DUDLEY ME, WUNDERLICH JR et al.: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science (2006) 314:126-129.
   PubMed Web of Science ®Google Scholar